Supporting frontline staff in frontotemporal degeneration research - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Enhancing the Role of Clinical Research Coordinators in Frontotemporal Degeneration Studies

  • By

  • Shana G. Dodge

  • Danelle J. Carter

  • Dahlia Kamel

  • Angela Lunde

  • Quinn Hlava

  • Kevin Nelson

  • Penny A. Dacks

  • September 11, 2026

Share

Clinical Report: Enhancing the Role of Clinical Research Coordinators in FTD Studies

Overview

A survey of Clinical Research Coordinators (CRCs) in frontotemporal degeneration (FTD) research revealed significant training deficiencies, particularly in genetics, symptom management, and brain donation.

Background

Frontotemporal degeneration (FTD) encompasses a group of neurodegenerative disorders that significantly impact behavior, communication, and motor function. The role of Clinical Research Coordinators (CRCs) is crucial in FTD research, as they are often the primary contact for participants and their families. However, the adequacy of CRC training and job satisfaction has not been systematically evaluated.

Data Highlights

FindingPercentage
CRCs feeling insufficiently prepared62%

Key Findings

  • 62% of CRCs reported feeling insufficiently prepared for their roles.
  • Key areas of training deficiency included genetics, symptom management, and brain donation.
  • Most CRCs had over 3 years of experience in their roles.
  • AFTD is developing modular training to enhance CRC competency.

Clinical Implications

The findings highlight the need for structured training programs for CRCs to improve their competency in managing FTD studies. Enhanced training may lead to better participant experiences and retention in clinical trials.

Conclusion

The study underscores the importance of adequate training and support for CRCs in FTD research to ensure effective participant engagement and retention.

Related Resources & Content

  1. Association for Frontotemporal Degeneration, Abstract, Year -- Enhancing the Role of Clinical Research Coordinators in FTD Studies
  2. ophthalmic professional — Survival Guide for New Study Coordinators
  3. BMC Psychiatry (Springer) — Study protocol for a randomized controlled trial assessing clinical efficacy of digital cognitive rehabilitation for preclinical and mild clinical stages of alzheimer’s disease continuum: the MI-RICORDO project
  4. Brain — Considerations for Trial Design in Preventing C9orf72-Related Diseases
  5. Acta Neuropathologica — Thorough Evaluation of TDP-43 Neuropathology Findings in the National Alzheimer’s Coordinating Center Database
  6. Survival Guide for New Study Coordinators
  7. Study protocol for a randomized controlled trial assessing clinical efficacy of digital cognitive rehabilitation for preclinical and mild clinical stages of alzheimer’s disease continuum: the MI-RICORDO project
  8. Considerations for Trial Design in Preventing C9orf72-Related Diseases
  9. ICH E6(R3) Good Clinical Practice guideline
  10. Alector Announces Topline Results from Latozinemab Phase 3 Trial in Individuals with Frontotemporal Dementia Due to a GRN Mutation
  11. Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working Group | Communications Medicine

Original Source(s)

Related Content